THE DOSE-RESPONSE RELATIONSHIP WITH ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - EFFECTS ON BLOOD-PRESSURE AND BIOCHEMICAL PARAMETERS

被引:24
作者
LEES, KR
机构
[1] University Department of Medicine and Therapeutics, Western Infirmary, Glasgow
关键词
ANGIOTENSIN CONVERTING ENZYME INHIBITORS; PHARMACODYNAMICS; BLOOD PRESSURE;
D O I
10.1097/00004872-199207005-00002
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Current usage: Plasma angiotensin converting enzyme (ACE) inhibition and dose-response relationships during blood pressure reductions were compared for several marketed ACE inhibitor compounds. Both peak and trough responses are considered and contrasted. The presently recommended antihypertensive doses of enalapril, lisinopril, perindopril and ramipril appear to lie within the linear range of the antihypertensive dose response relationship. For benazepril and captopril, the recommended doses may be in the flat, upper part of the relationship. Recommendations: The recommended doses for initiating antihypertensive therapy may still be excessive in patients at risk of heightened pharmacodynamic responses. Further studies are required to clarify the dose response relationship for all of these compounds.
引用
收藏
页码:S3 / S11
页数:9
相关论文
共 55 条
[1]   THE PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIPS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, CILAZAPRIL, IN ESSENTIAL-HYPERTENSION [J].
AJAYI, AA ;
ELLIOTT, HL ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :167-175
[2]   ACUTE AND CHRONIC EFFECTS OF THE CONVERTING ENZYME-INHIBITORS ENALAPRIL AND LISINOPRIL ON REFLEX CONTROL OF HEART-RATE IN NORMOTENSIVE MAN [J].
AJAYI, AA ;
CAMPBELL, BC ;
HOWIE, CA ;
REID, JL .
JOURNAL OF HYPERTENSION, 1985, 3 (01) :47-53
[3]  
ANDERSON T, 1981, NEW ENGL J MED, V304, P1550
[4]   ACUTE DOSE-RESPONSE CURVE OF ENALAPRIL IN RENOVASCULAR HYPERTENSIVES [J].
ARZILLI, F ;
MAGAGNA, A ;
GIOVANNETTI, R ;
NUCCORINI, A ;
SALVETTI, A .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) :S75-S78
[5]  
BELLET M, 1990, J HYPERTENS, V8, pS43
[6]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - RELATIONSHIP BETWEEN PHARMACODYNAMICS AND PHARMACOKINETICS [J].
BELZ, GG ;
KIRCH, W ;
KLEINBLOESEM, CH .
CLINICAL PHARMACOKINETICS, 1988, 15 (05) :295-318
[7]   VASCULAR EFFECTS OF INTRAVENOUS-INFUSION OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR PERINDOPRILAT [J].
BENETOS, A ;
SANTONI, JP ;
SAFAR, ME .
JOURNAL OF HYPERTENSION, 1990, 8 (09) :819-826
[8]   EFFECTIVE DOSE RANGE OF ENALAPRIL IN MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
BERGSTRAND, R ;
HERLITZ, H ;
JOHANSSON, S ;
BERGLUND, G ;
VEDIN, A ;
WILHELMSSON, C ;
GOMEZ, HJ ;
CIRILLO, VJ ;
BOLOGNESE, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (05) :605-611
[9]   3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].
BIOLLAZ, J ;
BURNIER, M ;
TURINI, GA ;
BRUNNER, DB ;
PORCHET, M ;
GOMEZ, HJ ;
JONES, KH ;
FERBER, F ;
ABRAMS, WB ;
GAVRAS, H ;
BRUNNER, HR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670
[10]   CAPTOPRIL - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE [J].
BROGDEN, RN ;
TODD, PA ;
SORKIN, EM .
DRUGS, 1988, 36 (05) :540-600